Success Stories: NIW Approval Secured for Neurohospitalist from Indonesia without RFE

Posted by wegreened on January 30, 2026 in Medical (Gastroenterology, Cancer, Cancer Pharmacology, Cardiology, Immunology, Pathology, Hematology, Neurology, Neuroscience, Urology, Gynecology, Dentistry, Endocrinology), NIW

Client’s Testimonial:

“Thank you for helping me with the petition. My I-140 has been approved. It’s such a relief after waiting for a while. I’ll keep checking the visa bulletin. It seems that I’ll wait another year before mine becomes current. I’ll retain you to file my I-485 as I’m very happy with the service.”

On August 28^th, 2025, we received another EB-2 NIW (National Interest Waiver) approval for a Neurohospitalist in the field of Vascular Neurology (Approval Notice).

General Field: Vascular Neurology

Position at the Time of Case Filing: Neurohospitalist

Country of Origin: Indonesia

State of Residence at the Time of Filing: Rhode Island

Approval Notice Date: August 28^th, 2025

Processing Time: 14 months

Case Summary:

We are pleased to announce the EB-2 NIW (National Interest Waiver) approval of a neurohospitalist from Indonesia whose research is advancing treatment and prevention strategies for cerebrovascular diseases. At the time of filing, the client was engaged in both clinical care and academic research focused on improving outcomes for patients with stroke and related conditions. North America Immigration Law Group (NAILG) prepared and submitted the case, which was approved in 14 months without RFE.

Proposed Endeavor: Advancing Stroke Treatment and Prevention

The client’s proposed endeavor centers on enhancing the treatment and prevention of cerebrovascular diseases by identifying effective acute interventions, developing secondary prevention strategies, and establishing modifiable risk factors that predict patient outcomes. Her research also addresses rare and complex presentations of cerebrovascular disease, thereby contributing to improved diagnostic precision and care strategies. Given the immense global and national burden of stroke, this endeavor carries clear public health and economic importance for the United States.

Notable Achievements Supporting the Petition

In support of this NIW petition, NAILG emphasized her academic and professional accomplishments, including:

Education and Training: Completed an MD degree, supported by extensive clinical and research experience.
Publications: Authored 9 peer-reviewed journal articles (5 first-authored), 3 other published articles, and 6 abstracts (4 first-authored), including work featured in top journals.
Citations: Her research has been cited 154 times, with multiple papers ranked among the top 0.1% and 20% most-cited neuroscience publications for their years of publication.
Research Contributions: Advanced understanding of antithrombotic therapies for cervical artery dissection, identified predictors of recurrent cerebral venous thrombosis, and investigated the role of statins in acute brain injury. Her findings have been adopted by other researchers to refine treatment protocols and improve patient outcomes.

NIW Approval and Outlook

This approval demonstrates how well-prepared evidence of national importance and individual merit can lead to a successful outcome. NAILG is honored to have represented this talented physician-scientist. Her continued work in vascular neurology will help reduce the burden of stroke, improve patient care, and strengthen the United States’ leadership in combating one of the most pressing public health challenges of our time.

--------------------------------------------

North America Immigration Law Group (Chen Immigration Law Associates) is a U.S. immigration law firm dedicated to representing corporations, research institutions, and individuals from all 50 U.S. states regarding I-140 immigration petitions. We specialize in employment-based immigration petition and have a proven record of high success rate for the categories of: EB2-NIW (National Interest Waiver), EB1-A (Alien of Extraordinary Ability), EB1-B (Outstanding Researcher/Professor) and O-1 (Alien of Extraordinary Ability).

Our Ten Thousand I-140 Approvals Provide Unprecedented Insight into the USCIS Adjudication Trend

With nearly 64,000 EB-1A, EB-1B, EB-2 NIW and O-1 cases approved, we have first hand information on the manner in which the USCIS adjudicate I-140 cases. As the USCIS has constantly changed its adjudication standards for the EB-1A, EB-1B and EB-2 NIW categories, our firm's huge database of successful cases gives you unprecedented insight to USCIS adjudication trends. We carefully analyze the data for all of our cases and apply the results of our analyses toward giving our clients up-to-date advice and adapting our strategies such that we remain on par with the ever-shifting landscape of immigration law in the U.S. With us, you will always have access to important updates, strategies, and information so that you can make the most informed decisions about your case.

We Have Helped Tens of Thousands of Clients with Credentials and Backgrounds Similar to Yours

With our exceedingly large number of successful petitions, no matter what credentials you have, no matter your background and field of expertise, no matter your visa status or nationality, chances are we have helped hundreds or even thousands of clients just like you. Our clients are usually impressed with how well we understand their research and work. Our insight and understanding stems from the fact that we have handled many cases with elements similar to yours already, and this helps us devise the best strategies for each individual petition.

Vast Majority of Clients Came to Us Because of Referrals

For years, our firm has attracted new clients based solely on word of mouth, recommendations, and the positive collaboration experiences shared with them by their friends and family. We take pride in our reputation and work hard to ensure that we provide a green card application experience that our clients are happy to share with their friends and colleagues. That is how our cumulative total of approved cases grew from 600 in 2013 to nearly 64,000 in 2025.

Track Record of Success EB-1 and NIW Approvals

(2020.01 - 2024.12)

Category	Approval or Refund^®		Approval or Refiling^TM
Category	Approved Sum	Success Rate	Approved Sum	Success Rate
NIW	28,946	99.52%	3,030	98.31%
EB1A	4,322	91.76%	2,870	88.91%
EB1B	793	98.51%	236	90.77%
Total	34,061	98.44%	6,136	93.39%